Search results

Jump to navigation Jump to search

Page title matches

  • ...><ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref> However, [[vasopressin] ...ld L, Maggioni AP, Swedberg K et al.| title=Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure
    2 KB (342 words) - 10:20, 17 October 2010
  • 12 bytes (1 word) - 10:21, 17 October 2010
  • 827 bytes (133 words) - 10:21, 17 October 2010
  • 12 bytes (1 word) - 10:21, 17 October 2010

Page text matches

  • ...><ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref> However, [[vasopressin] ...ld L, Maggioni AP, Swedberg K et al.| title=Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure
    2 KB (342 words) - 10:20, 17 October 2010
  • ....<ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref><ref name="pmid20538391"
    3 KB (438 words) - 15:28, 22 May 2011
  • ...PMID 16286160</ref> Other [[vasopressin]] antagonists ([[conivaptan]], [[tolvaptan]], [[relcovaptan]], [[lixivaptan]]) act mainly on V1a [[cell surface recept ....<ref>(2009) [http://www.medicalletter.org/restricted/articles/w1326c.html Tolvaptan (Samsca) for Hyponatremia] The Medical Letter</ref>
    15 KB (1,951 words) - 10:35, 8 August 2011
  • ...tcome Trial. JAMA 2007;297:1319-31. Epub 2007 Mar 25. PMID 17384437</ref> Tolvaptan is a selective [[cell surface receptor]]s V2 antagonist in the distal nephr
    13 KB (1,669 words) - 07:45, 9 June 2014
  • ...tcome Trial. JAMA 2007;297:1319-31. Epub 2007 Mar 25. PMID 17384437</ref> Tolvaptan is a selective [[cell surface receptor]]s V2 antagonist in the distal nephr
    73 KB (10,150 words) - 21:46, 20 August 2014